Filing Details
- Accession Number:
- 0001209191-18-008227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-07 18:26:06
- Reporting Period:
- 2018-02-05
- Accepted Time:
- 2018-02-07 18:26:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-05 | 1,942 | $86.52 | 41,105 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-02-05 | 2,578 | $77.31 | 43,683 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-05 | 378 | $158.55 | 43,305 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-05 | 700 | $159.93 | 42,605 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-05 | 300 | $160.97 | 42,305 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-05 | 300 | $161.93 | 42,005 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-05 | 600 | $163.79 | 41,405 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-05 | 2,242 | $164.93 | 39,163 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-05 | 1,942 | $0.00 | 1,942 | $86.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-05 | 2,578 | $0.00 | 2,578 | $77.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,299 | 2027-02-02 | No | 4 | M | Direct | |
| 0 | 2024-02-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 882 | Indirect | 401(k) |
| Common Stock | 12,215 | Indirect | Held in Trust |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $158.55 (range $158.24 to $159.09).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $159.93 (range $159.46 to $160.47).
- Open market sales reported on this line occurred at a weighted average price of $160.97 (range $160.51 to $161.26).
- Open market sales reported on this line occurred at a weighted average price of $161.93 (range $161.70 to $162.39).
- Open market sales reported on this line occurred at a weighted average price of $163.79 (range $163.23 to $164.22).
- Open market sales reported on this line occurred at a weighted average price of $164.93 (range $164.31 to $165.06).
- The option vests in 16 quarterly installments from 2/3/2017.
- Fully vested.
Billionaire Hedge Funds
